Leslie Norwalk V.'s Insider Trades & SAST Disclosures
Leslie Norwalk V.'s most recent trade in CVS Health Corp was a trade of 2,200 Common Stock done at an average price of $57.1 . Disclosure was reported to the exchange on Nov. 21, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Leslie Norwalk V..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CVS Health Corp | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 57.10 per share. | 21 Nov 2024 | 2,200 | 2,200 (0%) | 0% | 57.1 | 125,620 | Common Stock |
| Globus Medical Inc - Ordin... | Leslie V. Norwalk | Director | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 11 Jul 2024 | 1,000 | 16,419 (0%) | 0% | 70 | 70,000 | Class A Common Stock |
| Arvinas Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 9,070 | 9,070 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 5,899 | 10,020 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences, Inc. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 2,982 | 2,982 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences, Inc. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,435 | 1,435 | - | - | Restricted Stock Unit | |
| Globus Medical Inc - Ordin... | Leslie V. Norwalk | Director | Sale of securities on an exchange or to another person at price $ 51.99 per share. | 15 Mar 2024 | 10,590 | 17,419 (0%) | 0% | 52.0 | 550,574 | Class A Common Stock |
| Neurocrine Biosciences, Inc. | V. Leslie Norwalk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.95 per share. | 27 Feb 2024 | 8,000 | 8,000 (0%) | 0% | 85.0 | 679,600 | Common Stock |
| Neurocrine Biosciences, Inc. | Leslie Norwalk V. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 8,000 | 1,724 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences, Inc. | Norwalk V. Leslie | Director | Sale of securities on an exchange or to another person at price $ 135.67 per share. | 27 Feb 2024 | 8,000 | 0 (0%) | 0% | 135.7 | 1,085,388 | Common Stock |
| ModivCare Inc | Norwalk Leslie V. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 2,658 | 18,830 (0%) | 0% | 0 | Common Stock | |
| Globus Medical Inc - Ordin... | Leslie Norwalk V. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 25,688 | 28,009 (0%) | 0% | - | Class A Common Stock | |
| Globus Medical Inc - Ordin... | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 2,321 | 2,321 (0%) | 0% | - | Class A Common Stock | |
| Arvinas Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 12,787 | 12,787 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 4,121 | 4,121 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences, Inc. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 4,290 | 4,290 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences, Inc. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 2,100 | 2,100 | - | - | Restricted Stock Unit | |
| ModivCare Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 1,314 | 16,172 (0%) | 0% | 0 | Common Stock | |
| Arvinas Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 10,192 | 10,192 | - | - | Stock Option (right to buy) | |
| Neurocrine Biosciences, Inc. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 9,724 | 9,724 | - | - | Non-Qualified Stock Option | |
| Centene Corp. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 82.02 per share. | 31 Mar 2022 | 381 | 1,481 (0%) | 0% | 82.0 | 31,250 | Common Stock |
| Centene Corp. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 10,000 | 10,000 | - | - | Common Stock Option (right to buy) | |
| ModivCare Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 1,223 | 14,858 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 1,100 | 1,100 (0%) | 0% | 0 | Common Stock | |
| Arvinas Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 7,511 | 7,511 | - | - | Stock Option (right to buy) | |
| Neurocrine Biosciences, Inc. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 8,833 | 8,833 | - | - | Non-Qualified Stock Option | |
| ModivCare Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 725 | 13,635 (0%) | 0% | 0 | Common Stock | |
| Arvinas Inc | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Neurocrine Biosciences, Inc. | Leslie V. Norwalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 6,018 | 6,018 | - | - | Non-Qualified Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges